Moderna stock sinks as patent case spurs concern for COVID-19 vaccine Annexon, Inozyme, iTeos snag $564M in upsized IPOs CymaBay resurrects seladelpar 8 months after NASH flop Sponsored: Rise in Targeted Therapies Drives Need for Flexible Small-Volume Manufacturing Parker Institute names Connolly as CSO, targets biopharma pacts Triplet Therapeutics nabs Scholar Rock R&D exec as new CSO Columbia team pinpoints potent antibody cocktail for COVID-19 As long waits for results render COVID-19 tests 'useless,' states seek workarounds FiercePharmaAsia—CanSino's COVID-19 vaccine data; AZ-SK supply deal; Chinese hackers Chutes & Ladders—Biogen CFO Capello steps down from role amid M&A speculation Featured Story | By Nick Paul Taylor A patent court has sided with Arbutus Biopharma in its dispute with Moderna, raising concerns that the intellectual property dispute could stymie COVID-19 vaccine development. The news sent shares in Moderna down 9% despite it being unclear whether the patent is relevant to its COVID-19 vaccine. read more |
| |
|---|
|
Top Stories By Amirah Al Idrus Annexon raised $251 million to advance treatments for neurodegenerative disease, rare disease biotech Inozyme bagged $112 million and cancer-focused iTeos Therapeutics picked up $201 million. All three surpassed their respective goals—Inozyme filed earlier this month to raise $86 million in its Wall Street debut, while Annexon and iTeos both took aim at $100 million listings. read more By Amirah Al Idrus In November, CymaBay Therapeutics stopped clinical development of its nonalcoholic steatohepatitis hopeful, seladelpar, after biopsies showed signs of liver damage in some patients. Now, the biotech is gearing up to revive the program after a panel of independent experts found no “chemical, biochemical or histological evidence” that the drug caused any liver injury. read more By Patheon, by Thermo Fisher Scientific Ensuring cohesion between drug substance chemists & drug product formulators is critical to manage risks & maximize rewards of transforming less soluble & bioavailable molecules into effective drugs. read more By Nick Paul Taylor The Parker Institute for Cancer Immunotherapy has named John Connolly, Ph.D., as its chief scientific officer. Connolly joins PICI having previously collaborated with the institute in his capacity as CSO of Tessa Therapeutics. read more By Ben Adams As Scholar Rock shakes up its C-suite, their loss has been startup Triplet Therapeutics’ gain as it nabs chief scientific officer Alan Buckler, Ph.D. read more By Angus Liu Researchers at Columbia University have isolated a cocktail of antibodies from COVID-19 patients they say could offer a new and potentially potent option for treating and preventing the disease. Some of the antibodies target areas of SARS-CoV-2 that are not addressed by drugs currently in development, they said. read more By Matt Volz,Phil Galewitz, Kaiser Health News HELENA, MONTANA—States frustrated by private laboratories’ increasingly long turnarounds for COVID-19 test results are scrambling to find ways to salvage their testing programs. read more By Angus Liu CanSino Biolgocis' adenovirus-vectored COVID-19 vaccine induced antibody and T-cell responses in mid-phase trial. AstraZeneca signs COVID-19 vaccine production deal with SK Bioscience. U.S. accuses two Chinese hackers of targeting COVID-19-related researches. And more. read more By Kyle Blankenship Biogen CFO Capello says goodbye; Rhythm Pharma grabs Genzyme vet for CEO role; Triplet takes on Buckler as CSO. read more | | Capture more value with your biotech equity Strategic planning for your early stage equity can result in a tax savings of up to $10 million as Qualified Small Business Stock. Harness works with serial scientific co-founders from top academic institutions and high growth company executives to find specialized financial advisors to help them capture more equity value. Learn more. |
Resources Sponsored by: Lonza Pharma & Biotech A novel spray-dried dispersion platform has been developed to faciliate high drug load applications Sponsored by: Florence Complimentary Download: How to connect to study sites remotely via the Electronic Investigator Site File (eISF) to streamline clinical operations. Insights from the largest eISF network in the world. Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. With today’s rapidly evolving environment, we have created this five-part content series to highlight pressing issues and topics that are more pertinent today than ever before. Sponsored by: Cambrex The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities, and employees than ever before, our experts have contributed more articles to our biggest eBook yet. Sponsored by: EVERSANA How predictive analytics and machine learning have the potential to transform healthcare by predicting “Patient Switching Behaviors.” Sponsored by: Recro Gainesville Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project. Sponsored by: Systech Get an inside look… Merck shares its next-generation approach to supply chain protection with new digital platforms, including Blockchain. Sponsored by: Automation Anywhere Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. The Bioprocessing Summit Virtual – Solving Today’s Challenges, Leading to Tomorrow’s Advances August 24-28, 2020 Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 